Global Intrathecal Pumps Market Growth 2023-2029

Global Intrathecal Pumps Market Growth 2023-2029

An intrathecal pump is a medical device used to deliver medications directly into the space between the spinal cord and the protective sheath surrounding the spinal cord. Medications such as baclofen, morphine, or ziconotide may be delivered in this manner to minimize the side effects often associated with the higher doses used in oral or intravenous delivery of these drugs.

Intrathecal pump is a surgically implanted system used to infuse potent medication directly into or around the spinal cord. These pumps are typically intended for use in chronic pain and spasticity management for delivering potent medicines in the intrathecal space which allows administration of drugs in very low doses.
LPI (LP Information)' newest research report, the “Intrathecal Pumps Industry Forecast” looks at past sales and reviews total world Intrathecal Pumps sales in 2022, providing a comprehensive analysis by region and market sector of projected Intrathecal Pumps sales for 2023 through 2029. With Intrathecal Pumps sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intrathecal Pumps industry.
This Insight Report provides a comprehensive analysis of the global Intrathecal Pumps landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intrathecal Pumps portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Intrathecal Pumps market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intrathecal Pumps and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intrathecal Pumps.
The global Intrathecal Pumps market size is projected to grow from US$ 263.7 million in 2022 to US$ 345.7 million in 2029; it is expected to grow at a CAGR of 345.7 from 2023 to 2029.
Medtronic is the main producer of Intrathecal Pumps, which holds about 85% of the market. North America is the biggest market, which holds half of the whole global market share.
This report presents a comprehensive overview, market shares, and growth opportunities of Intrathecal Pumps market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Constant Rate Pump
Programmable Pump
Segmentation by application
Chronic Pain
Spasticity Management
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Codman & Shurtleff (J&J)
Flowonix
Tricumed
Key Questions Addressed in this Report
What is the 10-year outlook for the global Intrathecal Pumps market?
What factors are driving Intrathecal Pumps market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intrathecal Pumps market opportunities vary by end market size?
How does Intrathecal Pumps break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.